#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uveal melanoma Obliterative bronchiolitis HER2 gene amplification Meningococcal immunisation Mastocytosis Pericarditis Hyperoxaluria Glycogen storage disease type II General anaesthesia Medulloblastoma Familial dilated cardiomyopathy Cardiac arrest Laryngeal squamous cell carcinoma Krabbe's disease Immune thrombocytopenia More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Trials in Disease Undifferentiated sarcoma Proteus syndrome Paroxysmal nocturnal haemoglobinuria Leiomyosarcoma recurrent – Life with Disease Antithrombin III deficiency – Diagnostics Haemophilia Urea cycle disorder – Basic Information Hairy cell leukaemia recurrent – Trials in Disease Von Willebrand’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CIRTUVIVINT Dydrogesterone Ly3556050 Cabotegravir Sodium Rebisufligene Etisparvovec Pf-07220060 Monohydrate Iberdomide VOXVOGANAN L-Threonine Escitalopram Oxalate Rilpivirine Hydrochloride Efpegerglucagon Metyrapone Bp Talazoparib Dobutamine NALMEFENE HYDROCHLORIDE Mavorixafor Vimseltinib Naloxone Hydrochloride Triamcinolone Hexacetonide More therapies…

    Learn about Your Condition

    Medication overuse headache Oral herpes Psoriatic arthropathy Metastases to peritoneum Torticollis Alport's syndrome Lyme disease Vertebrobasilar stroke Atopic keratoconjunctivitis Penile cancer Apathy Lichen sclerosus Limb reduction defect Interstitial lung disease Colorectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Behavior and Behavior Mechanisms

  • Study on the Effects of Escitalopram, Naltrexone, and Their Combination on Reducing Symptoms of Compulsive Sexual Behavior Disorder in Affected Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Naltrexone Hydrochloride
    • Escitalopram Oxalate
    Poland

  • Study on the Effects of Vortioxetine on Cognitive Function in Patients with Early Schizophrenia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Vortioxetine Hydrobromide
    • Chlorpromazine Hydrochloride
    • Haloperidol Decanoate
    Spain

  • Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Lisdexamfetamine Dimesylate
    • Methylphenidate Hydrochloride
    Poland

  • Study on the Effectiveness of Hormonal Treatment with Estradiol Hemihydrate and Testosterone in Adolescents with Gender Dysphoria

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Estradiol Hemihydrate
    • Testosterone
    France

  • Study on Oxytocin Treatment for Children with Autism and Intellectual Disability

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on Arbaclofen for Improving Social Function in Children and Adolescents with Autism Spectrum Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Arbaclofen
    France Spain
Previous Page
1 2 3 4 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!